Skip to content

Insights

Thought Leadership

GATC Health brings together visionary scientists, technologists, and entrepreneurs—driven by a shared mission to transform the biopharma industry and a bold vision of a future where effective treatment is within reach for every disease.

Latest Insights (Articles)

Chondrocyte and Mesenchymal Stem Cell–Based Regenerative Therapies for Osteoarthritis and Degenerative Bone Disorders

Mechanistic Artificial Intelligence for Personalized Drug Therapy: Integrating Pharmacokinetics, Pharmacodynamics, Therapeutic Drug Monitoring, and Multiomic Systems Biology

Coal Workers’ Pneumoconiosis in the 21st Century: Emerging Trends, Treatment Gaps, and Prognostic Uncertainties in a Resurgent Occupational Lung Disease

Video Library

From Addiction to Innovation: Dr. Stephen Loyd on Fighting the Opioid Crisis with AI

From Addiction to Innovation: Dr. Stephen Loyd on Fighting the Opioid Crisis with AI

Dr. Stephen Loyd shares his journey from addiction recovery to innovation in addiction medicine with AI.
GATC Health – COO Tyrone Lam Explains the AI-Based Molecule Discovery Model

GATC Health – COO Tyrone Lam Explains the AI-Based Molecule Discovery Model

Tyrone Lam details GATC's AI-driven approach to molecule discovery.
GATC Health: Accelerating the Future of Medicine with AI – Breakthrough in Opioid Use Disorder

GATC Health: Accelerating the Future of Medicine with AI – Breakthrough in Opioid Use Disorder

Opioid Use Disorder (OUD) is a chronic brain disease that causes compulsive opioid use, leading to dependence, withdrawal, and often fatal …